SCHEMBL7297953

SCHEMBL7297953

O=C1C=CC(=O)CC2C=CC(CC2)C1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678634 0.69
SCHEMBL2842442 0.69
Benzoquinone SCHEMBL984234 0.65 MAOA (0.42)
SCHEMBL6561371 0.63
SCHEMBL11179705 0.63
SCHEMBL3276103 0.63
SCHEMBL137542 0.63
Maleic Anhydride SCHEMBL219660 0.62
SCHEMBL13508673 0.61
SCHEMBL3898157 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0455195-B1 Ethanobicyclic amine derivatives for CNS disorders SEARLE & CO (US) 1997-10-22 EP disclosed
US-5215992-A Treating psychotic, convulsive, dystonic disorders, cerebral ischemia G. D. SEARLE & CO. (US) 1993-06-01 US disclosed
US-5089506-A Antipsychotic agents, anticonvulsants G. D. SEARLE & CO. (US) 1992-02-18 US disclosed
EP-0455195-A2 Ethanobicyclic amine derivatives for CNS disorders G.D. Searle & Co. (US) 1991-11-06 EP disclosed